“Bullish on Torrent Pharma, recommending a buy at ₹4,965 with a stop loss at ₹4,700 and a target of ₹5,450, implying up to 10% returns. The stock is showing early signs of strength after taking support around its 20-Day and 50-Day EMAs, where strong accumulation has been witnessed. This support zone is reinforced by a previous higher-high breakout area, indicating the stock is holding its breakout structure and attracting buying interest.”